Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug approved in the country for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and people. The medication functions as a https://sandozlisdexamfetamineon718374.theblogmystery.com/61946006/vyvanse-in-canada-a-comprehensive-explanation